Strategic Ecosystem Partnership Grant recipients
Strategic Ecosystem Partnership Grant recipients
Read an overview of the SERP Grant projects that we’re currently funding.
Developing state-of-the art molecular genetic testing in cancer diagnosis and monitoring
Dr Brown’s project seeks to develop testing and screening mechanisms for types of MPN, MDS, AML, and myeloma.
Establishing a new prognostic score for Follicular Lymphoma to rationalise therapeutic decision-making and improve patient outcomes
This project aims to devise new treatments for NHL which are less toxic and more effective.
Deep profiling of ALL and myeloma for targeted therapies
This project will use a new technology, mass cytometry CyTOF, to study how blood cancers develop resistance to therapy.
Understanding the process of progression from MDS to acute leukaemia
Prof Lane’s group is using sophisticated methods to understand how normal stem cells turn into leukaemia.
Characterisation of a novel DCAF factor as a blood cancer therapy
This project will develop lead drug candidates in a series of translational experiments designed to accelerate progression to human trials.
Precision Medicine in acute lymphoblastic leukaemia
This project is looking to introducing a more personalised approach to care for patients with ALL.
The Centre for Blood Transplant and Cell Therapy
The CBTCT is a newly funded Centre of Research Excellence (CRE) endorsed by the National Health and Medical Research Council (NH&MRC) to develop a world class, multi-centre approach to design and deliver improved therapies for people with blood cancers.
The role of the bone marrow microenvironment in the myeloma plasma cell dormancy and reactivation – toward a cure for myeloma
This project will develop a diagnostic test to identify stages of indolent myeloma.